Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services released proposed regulations for the 2023 Medicare Advantage and Part D plan year.
The U.S. Supreme Court held oral arguments on whether to allow the Centers for Medicare & Medicaid Services’ and Occupational Safety and Health Administration’s vaccine mandates to go into effect while appeals are heard in the courts of appeals.
The AHA has posted updated guidance to help hospitals and clinicians use ICD-10-CM “Z codes” to capture data on the social needs of patient populations, including non-medical factors that may influence a patient’s health status.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., recommended 12-15 year olds receive a single booster dose of the Pfizer COVID-19 vaccine at least five months after the initial two-dose series, expanding the agency’s recommendation for 16 and 17 year olds to younger…
The AHA released its latest edition of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The U.S. Supreme Court will hold oral arguments on whether to allow the Centers for Medicare & Medicaid Services’ and Occupational Safety and Health Administration’s vaccine mandates to go into effect while appeals are heard in the courts of appeals.
Million Hearts, a national initiative co-led by the Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services, recently named the Missouri Hospital Association a 2021 Hypertension Control Exemplar for its outstanding efforts to prioritize hypertension control…
John Riggi, AHA’s national advisor for cybersecurity and risk, discusses insights and lessons learned from hospital leaders from Dickinson County Healthcare System in Iron Mountain, Mich, and Sky Lakes Medical Center in Klamath Falls, Ore., after becoming victims of major ransomware attacks in the…
The Department of Health and Human Services amended its declaration providing liability protection under the Public Readiness and Emergency Preparedness Act to expand the category of “qualified persons” who are protected under the Act.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended a single booster dose of the Pfizer COVID-19 vaccine for 12-17 year olds at least five months after receiving a second dose.